Home » Topics » Disease categories and therapies » Cardiovascular

Cardiovascular
RSS

Pfizer returns development rights for BioBypass to GenVec

Jan. 28, 2002

Pieris and CytoTools collaborate to discover human Anticalins for atherosclerosis

Jan. 25, 2002

Clinical testing of potentially safer amlodipine isomer begins at Sepracor

Jan. 25, 2002

KB-130015: a potential antiarrhythmic agent with an improved safety profile compared to amiodarone

Jan. 24, 2002

Nippon Shinyaku reports series of heterocyclic compounds useful in cardiovascular diseases

Jan. 23, 2002

Patient treatment commences in phase II trial of RSD-1235 in atrial fibrillation

Jan. 22, 2002

Nippon Shinyaku scientists design tropolone derivatives that inhibit 12-lipoxygenase

Jan. 21, 2002

Hydroxyfasudil, a Rho kinase inhibitor with antianginal effects

Jan. 21, 2002

Cytomyx and Papworth Hospital enter cardiovascular collaboration

Jan. 21, 2002

Potent and selective ETA receptor antagonist potently lowers blood pressure in rats

Jan. 18, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 2, 2026.
Small-molecule TREM2 agonist advances to treat Alzheimer’s
BioWorld Science
Microglia play a central role in the neuroinflammation associated with Alzheimer’s disease (AD). These cells act as the brain’s immune system and respond to...
Amlogenyx’s AM-805 reduces amyloid plaques in AD
BioWorld Science
The potent carboxypeptidase enzyme protective protein cathepsin A (PPCA) is known to cleave the C-terminus of amyloid-β42, responsible for aggregation and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 31, 2026
Atai Therapeutics patents new 5-HT2 receptor agonists
BioWorld Science
Atai Therapeutics Inc. has identified new 5-HT2 receptor agonists potentially useful for the treatment of psychiatric disorders.